Nicholas Investment Partners LP Holding in Aerie Pharmaceuticals (AERI) Cut as Share Value Declined; Chapter Iv Investors Has Cut Holding in Eqt (EQT) as Market Valuation Declined

December 7, 2017 - By Louis Casey

Nicholas Investment Partners Lp decreased its stake in Aerie Pharmaceuticals Inc (AERI) by 12.82% based on its latest 2017Q2 regulatory filing with the SEC. Nicholas Investment Partners Lp sold 10,559 shares as the company’s stock declined 8.47% while stock markets rallied. The institutional investor held 71,800 shares of the health care company at the end of 2017Q2, valued at $3.77M, down from 82,359 at the end of the previous reported quarter. Nicholas Investment Partners Lp who had been investing in Aerie Pharmaceuticals Inc for a number of months, seems to be less bullish one the $2.11B market cap company. The stock decreased 2.55% or $1.5 during the last trading session, reaching $57.4. About 335,271 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 180.20% since December 7, 2016 and is uptrending. It has outperformed by 163.50% the S&P500.

Chapter Iv Investors Llc decreased its stake in Eqt Corp (EQT) by 30.43% based on its latest 2017Q2 regulatory filing with the SEC. Chapter Iv Investors Llc sold 175,000 shares as the company’s stock declined 9.10% while stock markets rallied. The hedge fund held 400,000 shares of the oil & gas production company at the end of 2017Q2, valued at $23.44M, down from 575,000 at the end of the previous reported quarter. Chapter Iv Investors Llc who had been investing in Eqt Corp for a number of months, seems to be less bullish one the $15.17 billion market cap company. The stock decreased 3.12% or $1.84 during the last trading session, reaching $57.18. About 2.89M shares traded. EQT Corporation (NYSE:EQT) has declined 18.61% since December 7, 2016 and is downtrending. It has underperformed by 35.31% the S&P500.




Investors sentiment decreased to 0.88 in 2017 Q2. Its down 0.14, from 1.02 in 2017Q1. It dropped, as 50 investors sold EQT shares while 152 reduced holdings. 56 funds opened positions while 122 raised stakes. 173.11 million shares or 10.68% more from 156.41 million shares in 2017Q1 were reported. Mycio Wealth Partners Ltd Limited Liability Company reported 0.12% stake. Advisory Services Limited Liability Co has invested 0% of its portfolio in EQT Corporation (NYSE:EQT). Millennium Mngmt Ltd Com has invested 0.11% in EQT Corporation (NYSE:EQT). Retirement Systems Of Alabama accumulated 84,033 shares or 0.03% of the stock. Amica Pension Fund Board Of Trustees holds 6,011 shares or 0.04% of its portfolio. United Automobile Association reported 0.01% stake. Quantitative Systematic Strategies Ltd Liability has invested 0.06% in EQT Corporation (NYSE:EQT). Commerce Bancorporation holds 0.01% or 6,856 shares. Old Mutual Customised Solutions (Proprietary) Limited has 4,300 shares. Gabelli Funds Ltd Liability Company holds 0.01% in EQT Corporation (NYSE:EQT) or 39,000 shares. Bridgewater Associates Ltd Partnership reported 0.01% of its portfolio in EQT Corporation (NYSE:EQT). Asset Mgmt stated it has 15,440 shares or 0.03% of all its holdings. Iowa-based Cambridge Investment Research Advisors has invested 0.01% in EQT Corporation (NYSE:EQT). Oakworth Cap reported 0% stake. New York-based Mutual Of America Management Limited Com has invested 0.02% in EQT Corporation (NYSE:EQT).

Analysts await EQT Corporation (NYSE:EQT) to report earnings on February, 1. They expect $0.30 earnings per share, up 20.00% or $0.05 from last year’s $0.25 per share. EQT’s profit will be $79.58M for 47.65 P/E if the $0.30 EPS becomes a reality. After $0.12 actual earnings per share reported by EQT Corporation for the previous quarter, Wall Street now forecasts 150.00% EPS growth.

Among 21 analysts covering EQT Corporation (NYSE:EQT), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. EQT Corporation had 70 analyst reports since July 21, 2015 according to SRatingsIntel. KLR Group upgraded the shares of EQT in report on Friday, October 23 to “Buy” rating. The company was maintained on Thursday, July 20 by RBC Capital Markets. On Thursday, October 13 the stock rating was downgraded by Tudor Pickering to “Hold”. The firm has “Outperform” rating by Credit Suisse given on Monday, October 24. JP Morgan initiated the stock with “Overweight” rating in Wednesday, December 9 report. The stock of EQT Corporation (NYSE:EQT) has “Hold” rating given on Friday, April 7 by Jefferies. On Monday, September 28 the stock rating was maintained by Deutsche Bank with “Buy”. The stock of EQT Corporation (NYSE:EQT) has “Buy” rating given on Friday, June 2 by RBC Capital Markets. On Thursday, November 9 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm earned “Sector Outperform” rating on Friday, July 14 by Howard Weil.

More recent EQT Corporation (NYSE:EQT) news were published by: Streetinsider.com which released: “EQT Corp. (EQT) Completes Acquisition of Rice Energy (RICE)” on November 13, 2017. Also Businesswire.com published the news titled: “EQT Announces Appointment of Two New Directors” on November 13, 2017. Seekingalpha.com‘s news article titled: “EQT-Rice Merger Arbitrage – Contrarians Harvesting A Handsome Return” with publication date: November 09, 2017 was also an interesting one.

Nicholas Investment Partners Lp, which manages about $1.37 billion and $1.42B US Long portfolio, upped its stake in Callaway Golf Co (NYSE:ELY) by 31,141 shares to 354,607 shares, valued at $4.53M in 2017Q2, according to the filing. It also increased its holding in Blueprint Medicines Corp by 15,339 shares in the quarter, for a total of 37,337 shares, and has risen its stake in Madden Steven Ltd (NASDAQ:SHOO).

Among 14 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 42 analyst reports since August 7, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) on Thursday, September 17 with “Buy” rating. The rating was maintained by Canaccord Genuity on Tuesday, August 1 with “Buy”. As per Friday, September 15, the company rating was maintained by Needham. As per Thursday, October 5, the company rating was maintained by Cowen & Co. As per Wednesday, November 4, the company rating was maintained by RBC Capital Markets. The firm has “Buy” rating given on Tuesday, September 26 by Cowen & Co. On Thursday, September 15 the stock rating was maintained by RBC Capital Markets with “Outperform”. The rating was maintained by JMP Securities on Friday, September 22 with “Buy”. The rating was maintained by H.C. Wainwright on Wednesday, August 2 with “Buy”. As per Wednesday, August 16, the company rating was maintained by Canaccord Genuity.

Investors sentiment increased to 1.17 in Q2 2017. Its up 0.21, from 0.96 in 2017Q1. It is positive, as 21 investors sold AERI shares while 48 reduced holdings. 33 funds opened positions while 48 raised stakes. 31.61 million shares or 3.55% more from 30.53 million shares in 2017Q1 were reported. California Pub Employees Retirement Sys stated it has 5,100 shares or 0% of all its holdings. 237 are owned by Tower Research Cap Ltd Liability Corp (Trc). 513 were reported by Fincl Bank Of Montreal Can. Dafna Capital Ltd Co holds 4% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) or 106,770 shares. Citadel Ltd Limited Liability Company holds 94,859 shares. Barclays Public Ltd has 0% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 3,431 shares. Phoenix Adviser owns 300 shares for 0.01% of their portfolio. California State Teachers Retirement Systems has invested 0.01% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Thrivent Financial For Lutherans holds 95,980 shares. Essex Investment Ltd Liability stated it has 76,707 shares or 0.58% of all its holdings. Driehaus Capital Mgmt accumulated 100,285 shares. First Personal Financial Svcs invested in 535 shares or 0.01% of the stock. Kazazian Asset Mgmt Ltd Liability Company has 8,558 shares for 0.68% of their portfolio. Gsa Cap Prtn Ltd Liability Partnership owns 0.02% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 4,906 shares. Tiaa Cref Inv Mngmt Limited Liability Company holds 0% or 124,238 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.